Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06000683 · ClinicalTrials.gov registry record · NA
Empowering Patients' Lung Cancer Screening Uptake
A NA study, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT06000683 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 79 participants.
The verdict
NCT06000683, a NA study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%. Yet many patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test the effect of a a multi-level intervention on ordering LDCT within 6 months after patient enrollment. Our proposed intervention includes (1) Primary care provider notifications of patients' LCS eligibility; (2) patients' education ; (3) patients' referral to financial navigation resources; and (4) patients' reminder to discuss LCS during PCP visit.
Interventions
- BEHAVIORAL Patient education
- BEHAVIORAL Referral to financial navigation resources
- BEHAVIORAL Patient Reminders
- BEHAVIORAL Provider Reminers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2023-10-13 |
| Est. Completion | 2025-11-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06000683
The ClinicalTrials.gov registry entry for NCT06000683 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Patient education is the first listed.
NCT06000683 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06000683 about?
NCT06000683 is a clinical study titled "Empowering Patients' Lung Cancer Screening Uptake". Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%. Yet many patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients...
What is the current status of trial NCT06000683?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2023-10-13. Estimated completion is 2025-11-25.
What interventions are being tested in trial NCT06000683?
The interventions under investigation include: Patient education (BEHAVIORAL), Referral to financial navigation resources (BEHAVIORAL), Patient Reminders (BEHAVIORAL), Provider Reminers (BEHAVIORAL).
Who is sponsoring clinical trial NCT06000683?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.